# | Title | Journal | Year | Citations |
---|
1 | Resting‐state network dysfunction in Alzheimer's disease: A systematic review and meta‐analysis | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2017 | 288 |
2 | Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2017 | 283 |
3 | Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2016 | 255 |
4 | Automatic speech analysis for the assessment of patients with predementia and Alzheimer's disease | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 217 |
5 | Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2016 | 209 |
6 | Consensus guidelines for lumbar puncture in patients with neurological diseases | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2017 | 197 |
7 | Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 191 |
8 | Body mass index in midlife and dementia: Systematic review and meta‐regression analysis of 589,649 men and women followed in longitudinal studies | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2017 | 169 |
9 | The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2018 | 169 |
10 | Machine learning of neuroimaging for assisted diagnosis of cognitive impairment and dementia: A systematic review | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2018 | 162 |
11 | Retinal thickness in Alzheimer's disease: A systematic review and meta‐analysis | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2017 | 152 |
12 | A systematic review and meta‐analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 133 |
13 | Cognitive impairment and decline in cognitively normal older adults with high amyloid‐β: A meta‐analysis | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2017 | 131 |
14 | Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2017 | 129 |
15 | Optimal cutoffs for the Montreal Cognitive Assessment vary by race and ethnicity | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2018 | 126 |
16 | Retinal microvascular network attenuation in Alzheimer's disease | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 122 |
17 | Association between air pollutants and dementia risk in the elderly | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 116 |
18 | Cognitive performance before and after the onset of subjective cognitive decline in old age | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 110 |
19 | Retinal blood flow in mild cognitive impairment and Alzheimer's disease | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 108 |
20 | Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer's disease | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 105 |
21 | The Quick Dementia Rating System (QDRS): A rapid dementia staging tool | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 100 |
22 | The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta‐analysis | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2019 | 100 |
23 | Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2019 | 95 |
24 | Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's disease | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2018 | 93 |
25 | Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2017 | 93 |
26 | Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle‐age adults at risk of AD | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 90 |
27 | The incidence of mild cognitive impairment: A systematic review and data synthesis | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2019 | 89 |
28 | Tau‐PET uptake: Regional variation in average SUVR and impact of amyloid deposition | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2017 | 86 |
29 | Tau positron emission tomography imaging in tauopathies: The added hurdle of off‐target binding | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2018 | 86 |
30 | Plasma tau complements CSF tau and P‐tau in the diagnosis of Alzheimer's disease | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2019 | 86 |
31 | Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2019 | 84 |
32 | The application of retinal fundus camera imaging in dementia: A systematic review | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2017 | 83 |
33 | Nonvascular retinal imaging markers of preclinical Alzheimer's disease | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2016 | 82 |
34 | Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 81 |
35 | Revolutionizing Alzheimer's disease and clinical trials through biomarkers | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 80 |
36 | Cerebral atrophy in mild cognitive impairment: A systematic review with meta‐analysis | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 79 |
37 | Repetitive head impact exposure and later‐life plasma total tau in former National Football League players | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2017 | 79 |
38 | Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 77 |
39 | Retinal thickness correlates with parietal cortical atrophy in early‐onset Alzheimer's disease and controls | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2018 | 77 |
40 | Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2019 | 77 |
41 | T‐MoCA: A valid phone screen for cognitive impairment in diverse community samples | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2021 | 74 |
42 | Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z‐scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2016 | 72 |
43 | White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2016 | 71 |
44 | Change in retinal structural anatomy during the preclinical stage of Alzheimer's disease | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2018 | 71 |
45 | Complement protein levels in plasma astrocyte‐derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer's disease dementia | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2019 | 70 |
46 | Measuring longitudinal cognition: Individual tests versus composites | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2019 | 69 |
47 | Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2016 | 68 |
48 | Computer mouse movement patterns: A potential marker of mild cognitive impairment | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2015 | 66 |
49 | Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [11C]PBB3‐PET study | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2017 | 66 |
50 | Developmental lead exposure and lifespan alterations in epigenetic regulators and their correspondence to biomarkers of Alzheimer's disease | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | 2016 | 65 |